Final answer:
Liver cirrhosis is a potential contraindication for a newly ordered antilipemic medication due to impaired liver function.
Step-by-step explanation:
Liver cirrhosis is a late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism. Each time your liver is injured, it tries to repair itself. In the process, scar tissue forms. As the cirrhosis progresses, more and more scar tissue forms, making it difficult for the liver to function.
The potential contraindication for a newly ordered antilipemic medication would be liver cirrhosis. Patients with liver cirrhosis often have impaired liver function, which can affect the metabolism and clearance of medications from the body. This can increase the risk of adverse effects and potential drug interactions.